The psychopharmacological treatment of depressive disorders in childhood and adolescence - Developments and standards since the «black box» warning;Psychopharmakologische behandlung von depressionen im kindes- und jugendalter - Entwicklungen und standards seit der «black box» warnung

Zeitschrift fur Kinder- und Jugendpsychiatrie und Psychotherapie

Volumn 40, Issue 6, 2012, Pages 365-371

  Plener, Paul L ^a   Fegert, Jörg M ^a   Kölch, Michael G ^a,b  

^a UNIVERSITY HOSPITAL ULM   (Germany)

^b MARTIN LUTHER KRANKENHAUS   (Germany)

Author keywords

Adolescents; Children; Depression; Psychopharmacological treatment; Selective serotonin reuptake inhibitors (SSRIs)

Indexed keywords

SEROTONIN UPTAKE INHIBITOR;

ADOLESCENT; CHILD; DEPRESSION; EVIDENCE BASED MEDICINE; FOOD AND DRUG ADMINISTRATION; GERMANY; HUMAN; PSYCHOPHARMACOTHERAPY; REVIEW; SUICIDE;

ADOLESCENT; ANTIDEPRESSIVE AGENTS; CHILD; DEPRESSIVE DISORDER; DEPRESSIVE DISORDER, TREATMENT-RESISTANT; DRUG LABELING; HUMANS; LONG-TERM CARE; SEROTONIN UPTAKE INHIBITORS; SUICIDE; TREATMENT OUTCOME; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 84868620616     PISSN: 14224917     EISSN: None     Source Type: Journal    
DOI: 10.1024/1422-4917/a000196     Document Type: Review

References (43)

1. Asarnow, J. R., Emslie, G., Clarke, G., Wagner, K. D., Spirito, A., Vitiello, B., . . . Brent, D. (2009). Treatment of selective serotonin reuptake inhibitor-resistant depression in adolescents: Predictors and moderators of treatment response. Journal of the American Academy of Child and Adolescent Psychiatry, 48, 330-339.
2. Birmaher, B., Brent, D. & the AACAP work group on quality issues. (2007). Practice parameters for the assessment and treatment of children and adolescents with depressive disorders. Journal of the American Academy of Child and Adolescent Psychiatry, 46, 1503-1526.
3. Brent, D. A. (2004). Antidepressants and pediatric depression - the risk of doing nothing. New England Journal of Medicine, 351, 1598-1601.
4. Brent, D. A., Emslie, G. J., Clarke, G. N., Asarnow, J., Spirito, A., Ritz, L. et al. (2009a). Predictors of spontaneous and systematically assessed suicidal adverse events in the treatment of SSRI-resistant depression in adolescents (TORDIA) study. American Journal of Psychiatry, 166, 418-426.
5. Brent, D. A., Emslie, G., Clarke, G., Wagner, K. D., Asarnow, J. R., Keller, M. & et al. (2008). Switching to another SSRI or to venlafaxine with or without cognitive behavioural therapy for adolescents with SSRI-resistant depression: The TORDIA randomized controlled trial. Journal of the American Medical Association, 299, 901-913. (Pubitemid 351397065)
6. Brent, D. A., Greenhill, L. L., Compton, S., Emslie, G., Wells, K., Walkup, J. T., . . . Turner, J. B. (2009b). The Treatment of Adolescent Suicide Attempters study (TASA): Predictors of suicidal events in an open treatment trial. Journal of the American Academy of Child and Adolescent Psychiatry, 48, 987-996.
7. Bridge, J. A., Iyengar, S., Salary, C. B., Barbe, R. P., Birmaher, B., Pincus, H. A., . . . Brent, D. A. (2004). Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment. Journal of the American Medical Association, 297, 1683-1696.
8. Brunner, R., Parzer, P., Haffner, J., Steen, R., Roos, J., Klett, M. & Resch, F. (2007). Prevalence and Psychological correlates of occasional and repetitive Deliberate Self-Harm in adolescents. Archives of Pediatrics and Adolescent Health, 161, 641-649. (Pubitemid 47026323)
9. Dt. Gesellschaft f. Kinder- und Jugendpsychiatrie und Psychotherapie. (Hrsg.). (2007). Leitlinien zur Diagnostik und Therapie von psychischen Störungen im Säuglings-, Kindes- und Jugendalter. Köln: Dt. Ärzteverlag.
10. Dubicka, B., Hadley, S. & Roberts, C. (2006). Suicidal behaviour in youths with depression treated with new-generation antidepressants: Meta-analysis. The British Journal of Psychiatry, 189, 393-398. (Pubitemid 44683169)
11. Emslie, G. J., Mayes, T., Porta, G., Vitiello, B., Clarke, G., Wagner, K. D., . . . Brent, D. (2010). Treatment of Resistant Depression in Adolescents (TORDIA):Week 24 outcomes. American Journal of Psychiatry, 167, 782-791.
12. Emslie, G. J., Ventura, D., Korotzer, A. & Tourkodimitris, S. (2009). Escitalporam in the treatment of Adolescent Depression: A randomized placebo-controlled multisite trial. Journal of the American Academy of Child and Adolescent Psychiatry, 48, 721-729.
13. Fegert, J. M. (2004). Depressionsbehandlung mit SSRI in der Kinder- und Jugendpsychiatrie Ein Forschungs- oder ein Informationsdebakel? Nervenheilkunde, 23, 61-67.
14. Fegert, J. M. & Herpertz-Dahlmann, B. (2004). Zum Einsatz von Serotoninwiederaufnahmehemmern (SSRI) bei depressiven Kindern und Jugendlichen. Zeitschrift für Kinder- und Jugendpsychiatrie und Psychotherapie, 32, 74-75. (Pubitemid 38714965)
15. Fegert, J. M., Kölch, M., Zito, J. M., Glaeske, G. & Janhsen, K. (2006). Antidepressant use in children and adolescents in Germany. Journal of Child and Adolescent Psychopharmacology, 16, 197-206.
16. Food and drug administration. (2007). Revisions to product labeling. Download unter http://www.fda.gov/downloads/Drugs/Drug-Safety/ InformationbyDrugClass/UCM173233.pdf
17. Gibbons, R. D., Brown, H., Hur, K., Davis, J. M. & Mann, J. J. (2012a). Suicidal thoughts and behaviour with antidepressant treatment. Archives of General Psychiatry. doi 10.1001/archgenpsychiatry.2011.2048.
18. Gibbons, R. D., Brown, C. H., Hur, K., Marcus, S. M., Bhaumik, D. K., Erkenes, J. A., . . . Mann, J. J. (2007). Early evidence on the effects of regulators suicidality warnings on SSRI prescriptions and suicide in children and adolescents. American Journal of Psychiatry, 164, 1356-1363. (Pubitemid 47461135)
19. Gibbons, R. D., Hur, K., Brown, C. H., Davis, J. M. & Mann, J. J. (2012b). Benefits from antidepressants: Synthesis of 6-week patient-level outcomes from double-blind placebo-controlled randomized trials of Fluoxetine and Venlafaxine. Archives of General Psychiatry. Epub ahead of print. doi: 10.1001/archpenpsychiatry.2011-2049
20. Goodyer, I., Dubicka, B., Wilkinson, P., Kelvin, R., Roberts, C., Byford, . . . Harrington, R. (2007). Selective serotonin reuptake inhibitors (SSRIs) and routine specialist care with and without cognitive behavior therapy in adolescents with major depression: Randomised controlled trial. British Medical Journal, 335, 142-150.
21. Hammad, T. A., Laughren, T. & Racoosin, J. (2006). Suicidality in pediatric patients treated with antidepressant drugs. Archives of General Psychiatry, 63, 332-339. (Pubitemid 43345358)
22. Hoffmann, F., Glaeske, G., Petermann, F. & Bachmann, C. J. (2012). Outpatient treatment in German adolescents with depression: An analysis of nationwide health insurance data. Pharmacoepidemiology Drug Safety, 21, 972-979.
23. Holsboer-Trachsler, E. & Holsboer, F. (2012) Antidepressiva. In G. Gründer & O. Benkert (Hrsg.), Handbuch der psychiatrischen Pharmakotherapie (2. Auflage, S. 589-629). Berlin, Heidelberg: Springer-Verlag.
24. Kokkevi, A., Rotsika, V., Arapaki, A. & Richardson, C. (2012). Adolescents' self-reported suicide attempts, self-harm thoughts and their correlates across 17 European countries. Journal of Child Psychology and Psychiatry, 53, 381-389.
25. Kölch, M., Pfalzer, A., Kliegl, K., Rothenhöfer, S., Ludolph, A. G., Fegert, J. M., . . . Gerlach, M. (2012). Therapeutic drug monitoring of children and adolescents using fluoxetine. Pharmacopsychiatry, 45, 72-76. (Pubitemid 46697678)
26. Kölch, M. G., Prestel, A., Singer, H., Keller, F., Fegert, J. M., Schlack, R., . . . Knopf, H. (2009). Psychotropic medication in children and adolescents in Germany: Prevalence, indications, and psychopathological patterns. Journal of Child and Adolescent Psychopharmacology, 19, 765-770.
27. Libby, A. M., Brent, D. A., Morrato, E. H., Orton, H. D., Allen, R. & Valuck, R. J. (2007). Decline in treatment of pediatric depression after FDA advisory on risk of suicidality with SSRIs. American Journal of Psychiatry, 164, 884-891. (Pubitemid 46972903)
28. Lynch, F. L., Dickerson, J. F., Clarke, G., Vitiello, B., Porta, G., Wagner, K. D., . . . Brent, D. (2011). Incremental cost-effectiveness of combined therapy vs medication only for youth with selective serotonin reuptake inhibitor-resistant depression: Treatment of SSRI-resistant depression in adolescents trial findings. Archives of General Psychiatry, 68, 253-262.
29. Maalouf, F. T., Atwi, M. & Brent, D. A. (2011). Treatment-resistant depression in adolescents: Review and updates on clinical management. Depression Anxiety, 28, 946-954.
30. Morrato, E. H., Libb, A. M., Orton, H. D., deGruy, F. V., Brent, D. A., Allen, R. & Valuck, R. J. (2008). Frequency of provider contact after FDA advisory on risk of pediatric suicidality with SSRIs. American Journal of Psychiatry, 165, 42-50. (Pubitemid 351704551)
31. National Institute for Health and Clinical Excellence. (2005). Depression in children and young people. Download unter http://www.nice.org.uk/CG28
32. Nemeroff, C. B., Kalali, A., Keller, M. B., Charney, D. S., Lenderts, S. E., Cascade, E. F. & et al. (2007). Impact of publicity concerning pediatric suicidality data on physician practice patterns in the United States. Archives of General Psychiatry, 64, 466-472. (Pubitemid 46556464)
33. Olfson, M., Marcus, S. C. & Druss, B. G. (2008). Effects of food and drug administration warnings on antidepressant use in a nationals sample. Archives of General Psychiatry, 65, 94-101.
34. Olfson, M., Shaffer, D., Marcus, S. C. & Greenberg, T. (2003). Relationship between antidepressant medication treatment and suicide in adolescents. Archives of General Psychiatry, 60, 978-982. (Pubitemid 37222079)
35. Plener, P. L., Libal, G., Keller, F., Fegert, J. M. & Muehlenkamp, J. J. (2009). An international comparison of adolescent nonsuicidal self-injury (NSSI) and suicide attempts: Germany and the USA. Psychological Medicine, 39, 1549-1558.
36. Safer, D. J. & Zito, J. M. (2006). Treatment-emergent adverse events from selective Serotonin reuptake inhibitors by age group: Children versus adolescents. Journal of Child and Adolescent Psychopharmacology, 16, 159-169.
37. Segrin, C. (2000). Social skills deficits associated with depression. Clinical Psychology Review, 20, 379-403.
38. Vitiello, B., Emslie, G., Clarke, G., Wagner, K. D., Asarnow, J. R., Keller, M. B., . . . Brent, D. A. (2011). Long-term outcome of adolescent depression initially resistant to selective serotonin reuptake inhibitor treatment: A follow-up study of the TORDIA sample. Journal of Clinical Psychiatry, 72, 388-396.
39. von Knorring, A. L., Olsson, G. I., Thomsen, P. H., Lemming, O. M. & Hulten, A. (2007). A randomized, double-blind, pacebo-controlled study of citalopram in adolescents with major depressive disorder. Journal of Clinical Psychopharmacology, 26, 311-315.
40. Wagner, K. D., Jonas, J., Findling, R. L., Ventura, D. & Saikali, K. (2006). A double-blind, randomized, placebo-controlled trial of escitalopram in the treatment of pediatric depression. Journal of the American Academy of Child and Adolescent Psychiatry, 45, 280-288.
41. Wagner, K. D., Robb, A. S., Findling, R. L., Jin, J., Gutierrez, M. M. & Heydorn, W. E. (2004). A randomized, placebo-controlled trial of citalopram for the treatment of major depression in children and adolescents. American Journal of Psychiatry, 161, 1079-1083. (Pubitemid 38735994)
42. Whittington, C. J., Kendall, T., Fonagy, P., Cottrell, D., Cotgrove, A. & Boddington, E. (2004). Selective Serotonin Reuptake Inhibitors in childhood depression: Systematic review of published versus unpublished data. The Lancet, 363, 1341-1345.
43. Yang, L. P. H. & Scott, L. J. (2010). Escitalopram in the treatment of major depressive disorder in adolescent patients. Pediatric Drugs, 12, 155-163.